Thalassemia: The test helps identify thalassemia, a blood disorder characterized by reduced hemoglobin production. Sickle Cell Anemia: It can diagnose sickle cell anemia, where genetic mutations lead to the formation of abnormal hemoglobin that affects red blood cell shape and function. Other Hemoglobin Disorders: The analysis detects other forms of hemoglobin disorders that may impair the blood’s ability to transport oxygen efficiently.

Individuals with Symptoms of Anemia: Such as fatigue, weakness, and pallor, to help determine the cause. People with a Family History of Hemoglobin Disorders: Such as thalassemia or sickle cell anemia. Travelers to Areas with High Rates of Genetic Disorders: For prevention and proper planning. Individuals Planning Pregnancy: To obtain genetic information that may affect the health of the fetus. Patients with Chronic Blood Disorders: To monitor treatment effectiveness.

Severe Fatigue: Persistent weakness and exhaustion. Pallor: Pale or unhealthy skin color. Abdominal Pain: Especially in cases of obstruction or spleen enlargement. Shortness of Breath: Particularly during physical activities. Changes in Urine Color: Such as dark color due to red blood cell breakdown. Family History of Hemoglobin Disorders: Such as thalassemia or sickle cell anemia.

What is the purpose of Beta-Globin Mutation 22 Analysis? It aims to identify genetic mutations associated with hemoglobin disorders, such as thalassemia and sickle cell anemia. How is the test performed? A sample of blood or tissue is taken and sent to the laboratory for DNA analysis. What are the expected normal levels? There are no “normal levels”; the results show either the presence or absence of mutations. Are there any special preparations before the test? Typically, no special preparations are needed, but it is advisable to consult a doctor regarding any instructions. How long does it take to get the results? Results may take from one week to several weeks, depending on the laboratory. How are the results used in treatment? The results help diagnose the condition, guide treatment options, and provide genetic counseling. What are the risks associated with the test? Risks are minimal, such as minor discomfort during sample collection, and the test is generally safe.

This test does not have "normal levels" like some other analyses, as it aims to detect the presence or absence of genetic mutations. Negative: indicating no mutations associated with disorders such as thalassemia or sickle cell anemia. Positive: indicating the presence of mutations that may suggest a risk for these disorders.

Beta Globin Genetic Mutation Test | Lahalak Platform

An advanced genetic test detecting 22 common mutations in the beta globin gene, supporting early diagnosis of hereditary blood disorders like thalassemia.

Prices starts from: 506.87 SAR

Scientific name: Beta Globin 22 Mutations Genetic Test

Beta Globin 22 Mutations analysis is a genetic test aimed at identifying the presence of mutations in the gene responsible for producing the beta chains of hemoglobin. These mutations are associated with several blood disorders, such as thalassemia and sickle cell anemia. This analysis helps accurately diagnose these conditions, enabling physicians...

Beta Globin 22 Mutations Genetic Test - Beta Globin Genetic Test

Service type Genetic and Chromosomal Test

Duration 15-20 minutes

Fasting Fasting is not required

Prices Starting from 506.87 SAR

Included Services

Beta Globin 22 Mutations Test
The optimal health guidance based on the result.
Personal support services from Lahalak

Medical Service Information

Purpose Test

Thalassemia: The test helps identify thalassemia, a blood disorder characterized by reduced hemoglobin production.
Sickle Cell Anemia: It can diagnose sickle cell anemia, where genetic mutations lead to the formation of abnormal hemoglobin that affects red blood cell shape and function.
Other Hemoglobin Disorders: The analysis detects other forms of hemoglobin disorders that may impair the blood’s ability to transport oxygen efficiently.

Recommended groups

Individuals with Symptoms of Anemia: Such as fatigue, weakness, and pallor, to help determine the cause.
People with a Family History of Hemoglobin Disorders: Such as thalassemia or sickle cell anemia.
Travelers to Areas with High Rates of Genetic Disorders: For prevention and proper planning.
Individuals Planning Pregnancy: To obtain genetic information that may affect the health of the fetus.
Patients with Chronic Blood Disorders: To monitor treatment effectiveness.

Symptoms indicative

Severe Fatigue: Persistent weakness and exhaustion.
Pallor: Pale or unhealthy skin color.
Abdominal Pain: Especially in cases of obstruction or spleen enlargement.
Shortness of Breath: Particularly during physical activities.
Changes in Urine Color: Such as dark color due to red blood cell breakdown.
Family History of Hemoglobin Disorders: Such as thalassemia or sickle cell anemia.

FAQs

What is the purpose of Beta-Globin Mutation 22 Analysis? It aims to identify genetic mutations associated with hemoglobin disorders, such as thalassemia and sickle cell anemia.
How is the test performed? A sample of blood or tissue is taken and sent to the laboratory for DNA analysis.
What are the expected normal levels? There are no “normal levels”; the results show either the presence or absence of mutations.
Are there any special preparations before the test? Typically, no special preparations are needed, but it is advisable to consult a doctor regarding any instructions.
How long does it take to get the results? Results may take from one week to several weeks, depending on the laboratory.
How are the results used in treatment? The results help diagnose the condition, guide treatment options, and provide genetic counseling.

Normal Levels

This test does not have "normal levels" like some other analyses, as it aims to detect the presence or absence of genetic mutations.
Negative: indicating no mutations associated with disorders such as thalassemia or sickle cell anemia.
Positive: indicating the presence of mutations that may suggest a risk for these disorders.